Neogenomics shares owned by Ubs Global Asset Management Americas
Quarter-by-quarter ownership of Neogenomics shares owned by Ubs Global Asset Management Americas
from 13F filings
Historical chart of Ubs Global Asset Management Americas investment in Neogenomics
Tip: Access up to 7 years of quarterly data
All positions including Neogenomics held by Ubs Global Asset Management Americas consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Neogenomics by Ubs Global Asset Management Americas
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2023-12-31 | $28M | 29M | 0.95 |
| 2023-09-30 | $27M | 29M | 0.92 |
| 2023-06-30 | $27M | 30M | 0.93 |
| 2023-03-31 | $27M | 30M | 0.93 |
| 2022-12-31 | $24M | 28M | 0.84 |
| 2022-09-30 | $24M | 28M | 0.86 |
| 2022-03-31 | $24M | 28M | 0.86 |
| 2021-12-31 | $34M | 28M | 1.18 |
| 2021-09-30 | $37M | 25M | 1.47 |
| 2021-06-30 | $32M | 22M | 1.42 |
| 2021-03-31 | $30M | 20M | 1.51 |
| 2020-12-31 | $32M | 20M | 1.62 |
| 2020-09-30 | $25M | 20M | 1.24 |
| 2020-06-30 | $24M | 22M | 1.08 |
More positions owned by Ubs Global Asset Management Americas
View all positions for Ubs Global Asset Management Americas